- Tags: myopia
Research
Research finds limited benefits of outdoor exposure for premyopic children
Protective effect of time outdoors observed in hyperopes and premyopic children after spending >120 minutes/day outside.
Research
Essilor Stellest 2.0 lenses demonstrate superior efficacy in slowing myopia progression
Upgraded FDA-authorized spectacle lenses for pediatric myopia control found to slow axial elongation more effectively after 1 year with advanced technology.
Pipeline
Sydnexis reports phase 3 topline data on SYD-101 eye drop for pediatric myopia
The STAR study met both primary and secondary endpoints for low-dose atropine formulation—just days after the FDA’s NDA rejection.
Research
Myopia may delay DR development and progression
Study used Mendelian randomization to identify a causal relationship between myopia and diabetic retinopathy.
Pipeline
FDA rejects Sydnexis’ NDA for low-dose atropine drop
SYD-101 still has the potential to become the first pharmaceutical option for progressive myopia for patients aged 3 to 14.
Products
Myopia Profile debuts AI virtual assistant for disease management
Ask Kate is trained to deliver real-time, evidence-based responses to help ECPs stay updated on the latest clinical and scientific research.
Events
GMAC launches free myopia awareness toolkit for ECPs
Downloadable resources include take-home brochures, social media graphics, and more to raise awareness and education of pediatric disease progression.
Research
National trial to test preventative atropine drops for pediatric myopia
The University of Houston and The Ohio State University researchers partner on NEI-funded study to test if low-concentrated drops delay onset of myopia.
Research
Do seasonal variations impact myopia treatment efficacy?
Researchers investigate whether the effect of orthokeratology varies base don the season.
Research
Current trajectory of global eyecare access unlikely to meet 2030 goal
Study advocates for global efforts to equitably increase spectacle coverage to achieve 2030 goal.
Research
New data finds increased prevalence of refractive surgery among cataract patients
Clinicians may need to consider new ways of calculating IOL power due to prevalence of high myopia and previous refractive surgery.
Research
Study identifies risk factors for myopic macular degeneration progression
Axial elongation was shown to be a key risk factor for progression, among others.
Pipeline
iVeena submits IND to FDA for pediatric myopia clinical trial
Company plans to initiate a multinational phase 2 study on IVMED-85, a PF and non-atropine daily eye drop intended to improve refraction and decrease AE rates.
Pipeline
New DOT lens data finds 75% pediatric myopia management efficacy after 12 months
Latest clinical results support safety and effectiveness of SightGlass Vision’s Diffusion Optics Technology spectacle lenses—including 1-year following discontinued wear.
Research
Air pollution exposure leading to more ocular disease cases among adults
Myopic eyes demonstrated increased risk of ocular disease with exposure to air pollution.
Research
New data supports Hoya's DIMS lenses for myopic prevention among preschool-aged pediatrics
Presented at ARVO, updated findings among the younger pre-myopics confirmed a protective effect of the patented and embedded technology on refractive status.
Research
MiSight 1 day lens 7-year data supports long-term myopia control
Clinical study on dual-focus contact lens notes retained treatment gains among myopic eyes even after discontinued wear.
Research
Potential link identified between myopia and reading in the dark
Differences in bedroom illumination before sleep may impact myopia onset and progression in children.
Research
Daily hour of screen time increases myopia risk by nearly 25%
Investigators report significant increase in myopia risk seen with up to 4 hours of daily screen time, after which the risk rose more gradually.
Products